Benzodiazepine Withdrawal Syndrome Seizures
H Martínez-Cano, Antonio Vela‐Bueno, M. de Iceta, Rolando Pomalima, Isabel Martínez‐Gras
Abstract
H Martínez-Cano, Antonio Vela‐Bueno, M. de Iceta, Rolando Pomalima, Isabel Martínez‐Gras
Abstract
In this study, we present five cases of seizures following withdrawal of flunitrazepam, lorazepam, or triazolam, representing 3% of a sample consisting of 153 patients dependent on benzodiazepines. Both abrupt cessation of benzodiazepine intake and high-dose use seem to be critical for the appearance of seizures. Pharmacological features, such as short elimination half-life and high potency, might explain the higher risk of seizures observed in these patients.
OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In this study, we present five cases of seizures following withdrawal of flunitrazepam, lorazepam, or triazolam, representing 3% of a sample consisting of 153 patients dependent on benzodiazepines. Both abrupt cessation of benzodiazepine intake and high-dose use seem to be critical for the appearance of seizures. Pharmacological features, such as short elimination half-life and high potency, might explain the higher risk of seizures observed in these patients.
Key concepts: Triazolam, Lorazepam, Flunitrazepam, Benzodiazepine, Withdrawal syndrome, Medicine, Kindling, Anesthesia